Pre-made Efdamrofusp Alfa benchmark antibody (Bispecific, anti-C3/CO3;C4B;VEGFA therapeutic antibody, Anti-AHUS5/ARMD9/ASP/CPAMD1/HEL-S-62p;CH/C4F/CO4/C4BD/C4B12/CPAMD3;VPF/MVCD1 Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-813

Pre-made Efdamrofusp Alfa benchmark antibody (Bispecific, anti-C3/CO3;C4B;VEGFA therapeutic antibody, Anti-AHUS5/ARMD9/ASP/CPAMD1/HEL-S-62p;CH/C4F/CO4/C4BD/C4B12/CPAMD3;VPF/MVCD1 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

VEGFR1/VEGFR2 fragments-IgG1 Fc-CR1 fusion protein: human vascular endothelial growth factor receptor 1 (VEGFR1) (104-204)- peptide (containing the Ig-like C2-type domain 2) (1-101) / human vascular endothelial growth factor receptor 2 (VEGFR2) (206-308)- peptide (containing the Ig-like C2-type domain 3) (102-204) / human immunoglobulin G1 heavy chain constant region C-terminal 227-peptide fragment (IgG1 Fc) (205-431) [human IGHG1*01; hinge: 205- 214; CH2: 215-324; CH3: 325-429; CHS: 430-431] / G6 peptide linker (432-437) / human complement receptor type 1 (CR1) [N29>K466, S37>Y474, G79>D516, D109>N546] (1-192)-peptide (438-629) fusion protein, dimer (210-210':213-213')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, glycoform alfa angiogenesis inhibit

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-813-1mg 1mg Inquiry
GMP-Bios-INN-813-10mg 10mg Inquiry
GMP-Bios-INN-813-100mg 100mg Inquiry
GMP-Bios-INN-813-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Efdamrofusp Alfa P Alfaiosimilar, Bispecific, Anti-C3/CO3;C4B;VEGFA Antibody: Anti-AHUS5/ARMD9/ASP/CPAMD1/HEL-S-62p;CH/C4F/CO4/C4BD/C4B12/CPAMD3;VPF/MVCD1 therapeutic antibody
INN Name Efdamrofusp Alfa
TargetC3/CO3;C4B;VEGFA
FormatBispecific
Derivation
Species Reactivity
CH1 Isotype
VD LC
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech